Dawnrays Pharmaceutical (Holdings) Limited

HK$0.91As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2348Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (3.00%)
Div yield 6.92%
ROE 6.91%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM 5.172
TSR TTM (19.47%)
Mkt cap HK$1.371B
ROIC 12.14%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.00
9.63%
1.14%
Buy 12|1|6|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
18.31%
11.57%
4.77%
10.44%
Revenue¥M
62.81
62.75
66.15
68.13
8.22%
2.75%
11.24%
14.89%
Peers (US$174.9M)
Cap (US$)
PE
167.8M
6.517x
178.9M
99.02x
Capital
TTM
5Y
10Y
Leveragex
3.208
(0.079)
(0.085)
EBIT/Intx
1.869
1.496
1.741
Own earn%
63.62
(10.79)
(0.95)
Sh yield%
34.27
36.59
39.60
Owners
Insiders/Inst%
4.57
42.11
Short interest%
4.66
SBC / revenue%
4.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
12